We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Next-Generation Deep Brain Stimulation Devices

By HospiMedica International staff writers
Posted on 11 Dec 2008
NeuroNexus Technologies (Ann Arbor, MI, USA) and Philips Research, a division of Royal Philips Electronics (Amsterdam, The Netherlands), have announced that they have signed a joint research agreement to develop next-generation deep brain stimulation devices (DBSs) with the aspiration to improve the treatment of neurological diseases and psychiatric disorders.

By combining Philips Research's strengths in microelectronics, signal processing, ultra-low power system design, and miniaturization, together with NeuroNexus Technologies' expertise in micro-scale electrode design and fabrication, the two companies aim to show the technical feasibility of highly programmable and magnetic resonance imaging (MRI)-safe deep brain stimulation devices--"brain pacemakers" that send electrical impulses to specific parts of the patient's brain via permanently inserted electrodes. More...
Their initial research will aim to meet the functional requirements of a DBS device for the treatment of Parkinson's disease.

"As neuroscientists become increasingly able to understand the language of the brain and fix neurological conditions with advanced electrical stimulation techniques, they will need a new generation of DBS devices that give them much greater flexibility in tailoring therapy," said Daryl Kipke, CEO of NeuroNexus Technologies. "With our unique microscale implantable electrode technology and Philips Research's integration expertise, we are well positioned to make a significant leap forward in delivering technologies that will support neurologists and neurosurgeons in improving patient treatment."

"Contributing to the development of MRI-compatible deep brain stimulation devices may ultimately allow us to combine DBS technology with our functional imaging, image-guided intervention and therapy planning capabilities to produce integrated treatment suites for neurodegenerative disease," said Henk van Houten, senior vice president of Philips Research, and head of it's healthcare research program. "It's yet another example of where the coming together of in-depth clinical knowledge and world-class technology expertise can work to the benefit of patients."

Parkinson's disease is a degenerative disorder of the central nervous system (CNS) that impairs people's motor skills and speech, leading to a progressive loss in quality of life.

Late-stage Parkinson's disease is increasingly being treated using deep brain stimulation; the pacemaker control unit is normally implanted into the patient's chest or abdomen, with a connecting lead routed under the skin to the brain electrode. However, patients may develop spine or other problems that would require further examination using MRI; with current implants, MRI scans are not possible due to the materials used in the fabrication of the DBS electrodes and the stimulators.

Related Links:
NeuroNexus Technologies
Royal Philips Electronics


Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Syringe Pump
SP50 Series
Surgical System
Stealth AXiS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Emergency Department Campaign Reduces CT Use Without Identified Missed Injuries

Unnecessary head and cervical spine computed tomography (CT) in low-risk trauma patients exposes them to avoidable radiation, prolongs emergency department stays, and increases healthcare costs.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.